Xconomy

From Cell Therapeutics, Still Fighting, Gets Zevalin Data Published In Cancer Journal:

ctilogo
ctilogo

Cell Therapeutics is developing pixantrone for non-Hodgkin’s lymphoma

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.